| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | HELP | 3.25e-04 | 6 | 88 | 2 | PF03451 | |
| Domain | DUSP | 3.25e-04 | 6 | 88 | 2 | PF06337 | |
| Domain | DUSP | 3.25e-04 | 6 | 88 | 2 | SM00695 | |
| Domain | HELP | 3.25e-04 | 6 | 88 | 2 | IPR005108 | |
| Domain | DUSP | 4.54e-04 | 7 | 88 | 2 | PS51283 | |
| Domain | - | 4.54e-04 | 7 | 88 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 4.54e-04 | 7 | 88 | 2 | IPR006615 | |
| Domain | LAM_G_DOMAIN | 7.57e-04 | 38 | 88 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 8.80e-04 | 40 | 88 | 3 | PF02210 | |
| Domain | EFh | 9.05e-04 | 158 | 88 | 5 | SM00054 | |
| Domain | CENP-B_N | 9.64e-04 | 10 | 88 | 2 | PF04218 | |
| Domain | LamG | 1.16e-03 | 44 | 88 | 3 | SM00282 | |
| Domain | HTH_Psq | 1.40e-03 | 12 | 88 | 2 | IPR007889 | |
| Domain | HTH_PSQ | 1.40e-03 | 12 | 88 | 2 | PS50960 | |
| Domain | CENPB | 1.40e-03 | 12 | 88 | 2 | SM00674 | |
| Domain | DDE_1 | 1.40e-03 | 12 | 88 | 2 | PF03184 | |
| Domain | DDE_SF_endonuclease_dom | 1.40e-03 | 12 | 88 | 2 | IPR004875 | |
| Domain | HTH_CENPB | 1.66e-03 | 13 | 88 | 2 | PS51253 | |
| Domain | HTH_Tnp_Tc5 | 1.66e-03 | 13 | 88 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 1.66e-03 | 13 | 88 | 2 | IPR006600 | |
| Domain | uDENN | 1.93e-03 | 14 | 88 | 2 | SM00800 | |
| Domain | uDENN | 2.21e-03 | 15 | 88 | 2 | PF03456 | |
| Domain | DENN | 2.52e-03 | 16 | 88 | 2 | SM00799 | |
| Domain | DENN | 2.52e-03 | 16 | 88 | 2 | PF02141 | |
| Domain | dDENN | 2.52e-03 | 16 | 88 | 2 | PF03455 | |
| Domain | UDENN | 2.52e-03 | 16 | 88 | 2 | PS50946 | |
| Domain | DDENN | 2.52e-03 | 16 | 88 | 2 | PS50947 | |
| Domain | dDENN | 2.52e-03 | 16 | 88 | 2 | SM00801 | |
| Domain | dDENN_dom | 2.52e-03 | 16 | 88 | 2 | IPR005112 | |
| Domain | uDENN_dom | 2.52e-03 | 16 | 88 | 2 | IPR005113 | |
| Domain | DENN | 2.52e-03 | 16 | 88 | 2 | PS50211 | |
| Domain | DENN_dom | 2.52e-03 | 16 | 88 | 2 | IPR001194 | |
| Domain | Laminin_G | 2.59e-03 | 58 | 88 | 3 | IPR001791 | |
| Domain | USP_CS | 3.73e-03 | 66 | 88 | 3 | IPR018200 | |
| Domain | ConA-like_dom | 3.77e-03 | 219 | 88 | 5 | IPR013320 | |
| Domain | FA58C | 4.35e-03 | 21 | 88 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.35e-03 | 21 | 88 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.35e-03 | 21 | 88 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.35e-03 | 21 | 88 | 2 | PS01286 | |
| Domain | USP_1 | 4.41e-03 | 70 | 88 | 3 | PS00972 | |
| Domain | UCH | 4.59e-03 | 71 | 88 | 3 | PF00443 | |
| Domain | USP_2 | 4.59e-03 | 71 | 88 | 3 | PS00973 | |
| Domain | EF_HAND_2 | 4.72e-03 | 231 | 88 | 5 | PS50222 | |
| Domain | USP_3 | 4.77e-03 | 72 | 88 | 3 | PS50235 | |
| Domain | USP_dom | 4.77e-03 | 72 | 88 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.77e-03 | 72 | 88 | 3 | IPR001394 | |
| Domain | EF_hand_dom | 4.81e-03 | 232 | 88 | 5 | IPR002048 | |
| Pubmed | TRIM66 WIZ SUGP2 SH3TC1 MTHFR FAT3 SMARCA1 QTRT2 DDX56 CSMD1 KIF18B DNA2 PCCA ANKRD52 CREBBP | 2.01e-07 | 1116 | 91 | 15 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAB10 ARRB2 DENND1B SUGP2 SH3TC1 TBC1D1 XPNPEP3 TBC1D14 SPACA6 DDX56 CACNA1H PRKD1 CHD6 CSMD1 PCCA CREBBP HPS3 | 2.84e-07 | 1489 | 91 | 17 | 28611215 |
| Pubmed | TET2 TRIM66 WIZ PPP3R1 RTRAF USP32 ARFGEF2 CHD6 ADAMTS8 HNRNPUL1 USP9Y CREBBP SLC4A3 ARCN1 USP33 | 1.19e-06 | 1285 | 91 | 15 | 35914814 | |
| Pubmed | 3.75e-06 | 12 | 91 | 3 | 25011556 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 22377704 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 35680906 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 37034227 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 26807827 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27835898 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29232556 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 31150793 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16476741 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27452469 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18215141 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25695618 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24429825 | ||
| Pubmed | Deubiquitinases and their emerging roles in β-arrestin-mediated signaling. | 2.03e-05 | 3 | 91 | 2 | 24377933 | |
| Pubmed | Sp1 and CREB regulate basal transcription of the human SNF2L gene. | 2.03e-05 | 3 | 91 | 2 | 18243132 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 19424180 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 19363159 | ||
| Pubmed | 4.31e-05 | 26 | 91 | 3 | 25013050 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ATG4B ARRB2 SUGP2 EML4 SMARCA1 DDX56 DGKD LTF HNRNPUL1 KIF18B ANKRD52 CREBBP ARCN1 | 5.04e-05 | 1353 | 91 | 13 | 29467282 |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 12943377 | ||
| Pubmed | Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. | 6.74e-05 | 5 | 91 | 2 | 15502848 | |
| Pubmed | ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer. | 6.74e-05 | 5 | 91 | 2 | 36114756 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.01e-04 | 6 | 91 | 2 | 34143959 | |
| Pubmed | Gene polymorphisms and osteoporotic fractures: a study in postmenopausal French women. | 1.01e-04 | 6 | 91 | 2 | 19299182 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 24706829 | ||
| Pubmed | 1.17e-04 | 418 | 91 | 7 | 34709266 | ||
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 1.26e-04 | 37 | 91 | 3 | 20937701 | |
| Pubmed | MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors. | 1.41e-04 | 7 | 91 | 2 | 23166351 | |
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 25740311 | ||
| Pubmed | Ca(2+)-binding proteins in the retina: from discovery to etiology of human disease(1). | 1.41e-04 | 7 | 91 | 2 | 11108966 | |
| Pubmed | 1.64e-04 | 591 | 91 | 8 | 15231748 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RAB10 SLC9C1 DENND4A EML4 TBC1D1 XPNPEP3 ATG2B QTRT2 PRKD1 HNRNPUL1 KIF18B CREBBP | 1.70e-04 | 1321 | 91 | 12 | 27173435 |
| Pubmed | 1.82e-04 | 199 | 91 | 5 | 23382691 | ||
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 35569195 | ||
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 19741118 | ||
| Pubmed | DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. | 1.88e-04 | 8 | 91 | 2 | 28614801 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.16e-04 | 462 | 91 | 7 | 31138677 | |
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 34873237 | ||
| Pubmed | Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. | 2.41e-04 | 9 | 91 | 2 | 18180038 | |
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 37149635 | ||
| Pubmed | 2.60e-04 | 215 | 91 | 5 | 35973513 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 24778262 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 18087039 | ||
| Pubmed | 3.65e-04 | 504 | 91 | 7 | 34432599 | ||
| Pubmed | 5.18e-04 | 13 | 91 | 2 | 20060823 | ||
| Pubmed | 6.04e-04 | 14 | 91 | 2 | 24811271 | ||
| Pubmed | 6.20e-04 | 551 | 91 | 7 | 34728620 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | C2CD3 WIZ SUGP2 MTMR14 SH3TC1 MTHFR ARFGEF2 DDX56 CACNA1H RAD9A | 6.31e-04 | 1105 | 91 | 10 | 35748872 |
| Pubmed | Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland. | 8.98e-04 | 17 | 91 | 2 | 28576768 | |
| Pubmed | 8.98e-04 | 17 | 91 | 2 | 26389685 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 8.98e-04 | 17 | 91 | 2 | 27725084 | |
| Pubmed | Loss of bone sialoprotein leads to impaired endochondral bone development and mineralization. | 8.98e-04 | 17 | 91 | 2 | 25464126 | |
| Pubmed | 9.34e-04 | 285 | 91 | 5 | 34369648 | ||
| Pubmed | 9.97e-04 | 777 | 91 | 8 | 35844135 | ||
| Pubmed | 1.08e-03 | 606 | 91 | 7 | 36538041 | ||
| Pubmed | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. | 1.25e-03 | 20 | 91 | 2 | 19626040 | |
| Pubmed | Ectodysplasin-A signaling is a key integrator in the lacrimal gland-cornea feedback loop. | 1.38e-03 | 21 | 91 | 2 | 31221639 | |
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.51e-03 | 22 | 91 | 2 | 26494785 | |
| Pubmed | 1.54e-03 | 645 | 91 | 7 | 25281560 | ||
| Pubmed | Genomic variants in an inbred mouse model predict mania-like behaviors. | 1.65e-03 | 23 | 91 | 2 | 29768498 | |
| Pubmed | 1.80e-03 | 24 | 91 | 2 | 24946904 | ||
| Pubmed | 1.80e-03 | 24 | 91 | 2 | 21821099 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RAB10 DENND4A ATG4B ARRB2 EML4 DDX56 LTF PFKFB3 HNRNPUL1 RGS2 | 1.94e-03 | 1284 | 91 | 10 | 17353931 |
| Pubmed | Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. | 1.95e-03 | 25 | 91 | 2 | 17035289 | |
| Pubmed | 2.27e-03 | 99 | 91 | 3 | 19730683 | ||
| Pubmed | 2.28e-03 | 27 | 91 | 2 | 26544073 | ||
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 2.28e-03 | 27 | 91 | 2 | 17525332 | |
| Pubmed | 2.28e-03 | 27 | 91 | 2 | 27621061 | ||
| Pubmed | 2.32e-03 | 513 | 91 | 6 | 25798074 | ||
| Pubmed | 2.45e-03 | 28 | 91 | 2 | 23006423 | ||
| Pubmed | 2.54e-03 | 103 | 91 | 3 | 32744500 | ||
| GeneFamily | Helix-turn-helix CENPB type domain containing | 1.09e-03 | 13 | 69 | 2 | 533 | |
| GeneFamily | Ubiquitin specific peptidases | 1.28e-03 | 56 | 69 | 3 | 366 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.34e-03 | 57 | 69 | 3 | 1179 | |
| GeneFamily | EF-hand domain containing | 1.49e-03 | 219 | 69 | 5 | 863 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-07 | 189 | 91 | 7 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 167 | 91 | 6 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.84e-06 | 179 | 91 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-06 | 181 | 91 | 6 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 2.09e-06 | 183 | 91 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-06 | 183 | 91 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-06 | 186 | 91 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-06 | 188 | 91 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-06 | 193 | 91 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 91 | 6 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-06 | 200 | 91 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-06 | 200 | 91 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-06 | 200 | 91 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 133 | 91 | 5 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 133 | 91 | 5 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.54e-06 | 135 | 91 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 162 | 91 | 5 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 162 | 91 | 5 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 162 | 91 | 5 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-05 | 168 | 91 | 5 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 170 | 91 | 5 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | ASK428-Epithelial-Secretory|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.60e-05 | 170 | 91 | 5 | 9e275c4a70f9866f770fbdb0fe14a577287fe290 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 170 | 91 | 5 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 172 | 91 | 5 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-05 | 176 | 91 | 5 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-05 | 177 | 91 | 5 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 177 | 91 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-05 | 178 | 91 | 5 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 180 | 91 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 180 | 91 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-05 | 180 | 91 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 181 | 91 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 3.50e-05 | 181 | 91 | 5 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-05 | 182 | 91 | 5 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 182 | 91 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 183 | 91 | 5 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 184 | 91 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 3.79e-05 | 184 | 91 | 5 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 184 | 91 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 3.89e-05 | 185 | 91 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.89e-05 | 185 | 91 | 5 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 186 | 91 | 5 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 186 | 91 | 5 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 186 | 91 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-05 | 187 | 91 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.09e-05 | 187 | 91 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.09e-05 | 187 | 91 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-05 | 188 | 91 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 189 | 91 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-05 | 189 | 91 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 190 | 91 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 4.41e-05 | 190 | 91 | 5 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 190 | 91 | 5 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 190 | 91 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.41e-05 | 190 | 91 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 190 | 91 | 5 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-05 | 191 | 91 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.53e-05 | 191 | 91 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-05 | 191 | 91 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.64e-05 | 192 | 91 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-05 | 192 | 91 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-05 | 192 | 91 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-05 | 192 | 91 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-05 | 193 | 91 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-05 | 193 | 91 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-05 | 194 | 91 | 5 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-05 | 194 | 91 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 91 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 195 | 91 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 4.99e-05 | 195 | 91 | 5 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.99e-05 | 195 | 91 | 5 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.99e-05 | 195 | 91 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 4.99e-05 | 195 | 91 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.99e-05 | 195 | 91 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.99e-05 | 195 | 91 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 196 | 91 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 196 | 91 | 5 | e38036a5dbaed1488e01616bdc7678b28968470b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-05 | 196 | 91 | 5 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 198 | 91 | 5 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 198 | 91 | 5 | 963f028bf5491fa2b38982828a32ab96dcc34bf4 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 5.50e-05 | 199 | 91 | 5 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.50e-05 | 199 | 91 | 5 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.63e-05 | 200 | 91 | 5 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.63e-05 | 200 | 91 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| Disease | brain connectivity measurement | 2.66e-05 | 400 | 88 | 8 | EFO_0005210 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.70e-04 | 36 | 88 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Mastocytosis | 2.17e-04 | 39 | 88 | 3 | EFO_0009001 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.43e-04 | 8 | 88 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 6.01e-04 | 227 | 88 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | triacylglycerol 52:1 measurement | 7.82e-04 | 14 | 88 | 2 | EFO_0010413 | |
| Disease | diastolic blood pressure, systolic blood pressure | 8.84e-04 | 670 | 88 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Lymphoma, Follicular, Grade 2 | 9.00e-04 | 15 | 88 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 9.00e-04 | 15 | 88 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 9.00e-04 | 15 | 88 | 2 | C1956130 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 9.00e-04 | 15 | 88 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Lymphoma, Large-Cell, Follicular | 9.00e-04 | 15 | 88 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 9.00e-04 | 15 | 88 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 9.00e-04 | 15 | 88 | 2 | C0079758 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 9.00e-04 | 15 | 88 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.13e-03 | 152 | 88 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 1.30e-03 | 550 | 88 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Lymphoma, Follicular | 1.61e-03 | 20 | 88 | 2 | C0024301 | |
| Disease | cortical thickness | LRRIQ1 DENND1B MTHFR FAT3 ARFGEF2 RORA ADAMTS8 EML1 PCCA RAB44 | 1.76e-03 | 1113 | 88 | 10 | EFO_0004840 |
| Disease | alcohol drinking | 1.85e-03 | 81 | 88 | 3 | EFO_0004329 | |
| Disease | hippocampal volume | 1.98e-03 | 297 | 88 | 5 | EFO_0005035 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.05e-03 | 84 | 88 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Coronary heart disease | 2.33e-03 | 24 | 88 | 2 | C0010068 | |
| Disease | Prostatic Neoplasms | 2.47e-03 | 616 | 88 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.47e-03 | 616 | 88 | 7 | C0376358 | |
| Disease | birth weight, parental genotype effect measurement | 2.65e-03 | 192 | 88 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | Sezary Syndrome | 2.94e-03 | 27 | 88 | 2 | C0036920 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDSLFSEFCDVVRKA | 101 | B9A014 | |
| LLVFEEAFFKFCRAQ | 771 | P48751 | |
| SDAFKFIVFLACLGV | 396 | Q4VNC0 | |
| GELTADVCFFFKTTV | 811 | Q9BZ76 | |
| GFAIEFKEKPREACF | 1551 | Q96PZ7 | |
| AGLERFTFAFEKDVE | 6 | A6NMK7 | |
| EEAEGFVVFLCKDRS | 51 | O95971 | |
| FCRARGRSEFKVFEA | 626 | Q9UP79 | |
| DFCEKEFVSALRTFL | 716 | Q9Y6D5 | |
| LFAFEEIDGVDVCFF | 1396 | Q92793 | |
| EFDRRLGTIICEAFF | 546 | Q96DT5 | |
| FEPFKDGEFCLRVFS | 491 | A6NHC0 | |
| DKDGDGRISFEEFCA | 141 | P63098 | |
| RKEAFFCLEFLLDNG | 526 | Q8NB46 | |
| PIDDFCTKFFVGTEE | 626 | Q8IWG1 | |
| LLCGVRDSEEFLDFF | 101 | Q6ZUJ8 | |
| GSLFFFLKEFQVCAD | 331 | Q9UH62 | |
| DTGKACGVDFEIRAF | 136 | P32121 | |
| FADVVQKFFESLFAC | 56 | Q2TB18 | |
| VAFFTCIEKIDPARF | 541 | Q96BY7 | |
| SIAVGFFCKTEDDFN | 316 | Q9Y4P1 | |
| CSVAFLKAVFAEFLA | 6 | P55064 | |
| IRFIEECSFVSDKDA | 626 | Q7Z401 | |
| GKTCVLFRFSDDAFN | 21 | P61026 | |
| FFQDCGAKERGFVTR | 51 | Q7Z6P3 | |
| TFCLKEFRGLLSFAE | 216 | Q99638 | |
| FEADTFFRFVKACTD | 231 | P42898 | |
| CDFGFARIIGEKSFR | 726 | Q15139 | |
| DRLSKGEEIFFFCFN | 381 | Q8NCE2 | |
| RRFSDLGFEVKCFND | 76 | P55212 | |
| LFSFGFEEELKSLLC | 171 | Q9NY93 | |
| AFLEFDKDRDGFISC | 36 | Q9NP86 | |
| FVEGCKAREAAFDAD | 121 | Q96D98 | |
| ECFFIFLDVSRDFVA | 471 | Q969U6 | |
| DADQRLFEAFVIFCG | 541 | Q9HCR9 | |
| FKAFFIESVCDDPTV | 146 | Q16875 | |
| FDCFRKTLFREGITG | 56 | O43772 | |
| EFARCLAAEDVVFIG | 151 | P05165 | |
| KDLTFVFDRVFGEAA | 66 | Q86Y91 | |
| SFFLEEKLVDNAGFC | 901 | Q96JM4 | |
| CFVDRLEGEVFFATR | 571 | P16112 | |
| LECIERGVDLFESFF | 261 | Q9H974 | |
| CLFFLKGTEGRERAF | 441 | Q5TID7 | |
| CFLAELLEFAEVIFA | 1281 | Q4AC94 | |
| AIDRFCKPDSDRFVF | 841 | Q8TD26 | |
| FFKAEEVIIADFCFL | 91 | Q8TDW7 | |
| FQKFDTFRILVCGGD | 366 | Q16760 | |
| IGFFDRAVTCIAFSK | 321 | O00423 | |
| TFERGVGCLDFSKAD | 361 | Q9HC35 | |
| LFCSFLDEGIVAKFK | 121 | Q15835 | |
| KFFQSCADVLAEEGE | 106 | Q9BRP7 | |
| ERCNILEAFDAFIFA | 131 | O95180 | |
| FSRKIFDFCIVDEAS | 751 | P51530 | |
| FVLTDIESKQRFGFC | 71 | Q6P3S1 | |
| VLGKDCNETSFFFEA | 261 | Q9HCS5 | |
| KLEECEEAFTAAFQG | 51 | W5XKT8 | |
| FLRFAVFCNGESVEE | 2301 | Q92736 | |
| CFDLIFAFDEIVALG | 106 | P48444 | |
| GELTADVCFFFKTTV | 811 | Q96NU0 | |
| DKFAENDVIGCFADF | 321 | Q9BUJ2 | |
| GFNCKDETEFRNFIV | 16 | Q9Y224 | |
| AFRAFLKSEFCEENI | 96 | P41220 | |
| ICFVGDKDARAAFIR | 261 | P28370 | |
| AKVVTFDCGNDIFEE | 886 | Q4G0N8 | |
| FRCLAENAGDVAFVK | 551 | P02788 | |
| DALFVAAGCKVEAFA | 31 | Q969F9 | |
| DKRFCFDIEVVERHG | 336 | A6NI28 | |
| GDFTKSFKEFIDACL | 241 | Q9P289 | |
| IFLNEEEKSFFSEGC | 376 | Q8TE82 | |
| EFCGEFFENRKGLSS | 1046 | O95785 | |
| KEEFEECLEKFFSTG | 41 | P60153 | |
| FEAFEEDRCFAPFLA | 456 | Q6UXD5 | |
| GEVCSAEDFKVVFTR | 176 | P78348 | |
| VFCRDGEEFLFRTAL | 606 | Q9P2M4 | |
| DVRKGCFIFETFSLD | 1096 | A4UGR9 | |
| AAREFCGSFQEFVEK | 151 | Q4W5G0 | |
| GIDVTLCEEAFFRFA | 196 | O00300 | |
| LCEEAFFRFAVPTKF | 201 | O00300 | |
| FCLEERDFEAGVFEL | 786 | O15455 | |
| CGFFDDNIRKDTFFL | 706 | O43511 | |
| FKSLGCEDFISFVFE | 391 | P35398 | |
| CEDFISFVFEFGKSL | 396 | P35398 | |
| RENEDKICFFAFGAG | 316 | A6NFA1 | |
| FDIIDKSDVFSRFGI | 316 | Q8IX01 | |
| DDTFSKKFEVLFCGR | 166 | Q86TI0 | |
| DVKSEACQRFFRDGL | 111 | O00507 | |
| SEVCKFLSARDFGER | 496 | O95789 | |
| FLYAKFEFECRARGA | 281 | Q9NQH7 | |
| DSEVAEAGRCLEVFF | 1126 | O15016 | |
| REGSFFGQTKVEECF | 771 | Q6N021 | |
| AAERFARCFGRTDFK | 106 | Q6NT04 | |
| FCFKVFDVDRDGVLS | 271 | Q8NFA0 | |
| DCLAAFFARDELKGD | 571 | Q8TEY7 |